KYUNG NAM PHARM

The current price of 053950 is 1204 KRW — it has decreased by 2.19% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange KYUNG NAM PHARM stocks are traded under the ticker 053950.

053950 stock is 3.51% volatile and has beta coefficient of 1.90. Check out the list of the most volatile stocks — is KYUNG NAM PHARM there?

Yes, you can track KYUNG NAM PHARM financials in yearly and quarterly reports right on TradingView.

053950 stock has fallen by 0.50% compared to the previous week, the month change is a 0.99% fall, over the last year KYUNG NAM PHARM has showed a 32.62% decrease.

053950 net income for the last quarter is ‪−15.10 B‬ KRW, while the quarter before that showed ‪−2.14 B‬ KRW of net income which accounts for −605.11% change. Track more KYUNG NAM PHARM financial stats to get the full picture.

No, 053950 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, 053950 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KYUNG NAM PHARM stock right from TradingView charts — choose your broker and connect to your account.

053950 reached its all-time high on Apr 16, 2007 with the price of 44859 KRW, and its all-time low was 1135 KRW and was reached on Oct 26, 2023.
See other stocks reaching their highest and lowest prices.

As of Apr 20, 2024, the company has 248.00 employees. See our rating of the largest employees — is KYUNG NAM PHARM on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KYUNG NAM PHARM technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KYUNG NAM PHARM stock shows the sell signal. See more of KYUNG NAM PHARM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KYUNG NAM PHARM EBITDA is ‪−3.85 B‬ KRW, and current EBITDA margin is −5.63%. See more stats in KYUNG NAM PHARM financial statements.